What the experiment compared
Forty-four people with fatty liver were randomized to ginger or placebo for twelve weeks. Both groups received diet and physical-activity advice. [1]
The ginger group improved on selected liver enzymes, inflammatory markers, insulin resistance and steatosis grade. Fibrosis and aspartate aminotransferase did not significantly improve relative to placebo. [1]
Interpretation and limits
The trial was small, short and tested supplementation alongside lifestyle advice. Its favorable markers do not show reversal of advanced scarring or establish a personal regimen. Funding and conflicts were not established from the abstract. [1]
A hypothetical distinction
Imagine a study reports less fat in an organ while a scarring measure remains unchanged. Calling the whole organ healed would erase the distinction between those outcomes.
| Detail | Interpretation |
|---|---|
| Steatosis | Fat-related endpoint |
| Fibrosis | Different endpoint |
| Whole-disease cure | Not implied |
Sources for this article
- Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study - PubMed
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.